US industry rejects study that questions safety of 510(k) process
This article was originally published in RAJ Devices
Executive Summary
US medtech industry association AdvaMed has said that a new study criticising the Food and Drug Administration's 510(k) pre-market notification review process is "fundamentally flawed"1,2.